Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) CFO Robert Andrade sold 10,000 shares of Fennec Pharmaceuticals stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $8.99, for a total transaction of $89,900.00. Following the completion of the transaction, the chief financial officer now owns 139,721 shares in […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,720,000 shares, an increase of 17.0% from the May 15th total of 1,470,000 shares. Approximately 7.9% of the shares of the stock are sold […]
Opaleye Management Inc. bought a new position in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm bought 272,200 shares of the company’s stock, valued at approximately $2,613,000. Other institutional investors also recently bought and sold shares of the company. UBS Group AG grew its stake in shares […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) Director Chris A. Rallis sold 1,758 shares of the company’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $7.36, for a total transaction of $12,938.88. Following the sale, the director now owns 31,033 shares in the company, valued at […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) Director Chris A. Rallis sold 1,758 shares of the business’s stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $7.36, for a total value of $12,938.88. Following the sale, the director now owns 31,033 shares of the company’s […]